Carregando...
Regulation Catches Up to Reality: Nonadjunctive Use of Continuous Glucose Monitoring Data
The FDA recently conducted an Advisory Panel meeting to evaluate the safety, efficacy, and benefits of granting a nonadjunctive label claim for the DEXCOM G5 Mobile continuous glucose monitoring (CGM) system. If approved, this claim will allow users to make day-to-day treatment decisions, including...
Na minha lista:
| Publicado no: | J Diabetes Sci Technol |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5375077/ https://ncbi.nlm.nih.gov/pubmed/27630249 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1932296816667749 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|